newsfilter
← Latest News
FDA Approved Drugs·

Approval of Vykat Xr, Nda #216665 (Type 2 - New Active Ingredient)

Approval Date: 03/26/2025; Drug Name: Vykat Xr, Nda #216665; Active Ingredients: DIAZOXIDE CHOLINE; Company: Soleno Therapeutics Inc; Submission Status: Approval; Submission Classification: Type 2 - New Active Ingredient; Application Number: 216665

Company
SOLENO THERAPEUTICS INC
Keywords
SOLENO THERAPEUTICS INC